Abstract 408: ACP-196, an orally bioavailable covalent selective inhibitor of Btk, modulates the innate tumor microenvironment, exhibits antitumor efficacy and enhances gemcitabine activity in pancreatic cancer
- DOI
- 10.1158/1538-7445.am2015-408
- Published
- 2015-08-01
- Container
- Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1538-7445.am2015-408,
title = {Abstract 408: ACP-196, an orally bioavailable covalent selective inhibitor of Btk, modulates the innate tumor microenvironment, exhibits antitumor efficacy and enhances gemcitabine activity in pancreatic cancer},
author = {Brian J. Lannutti and Michael Gulrajani and Fanny Krantz and Elena Bibikova and Todd Covey and Katti Jessen and Wayne Rothbaum and David M. Johnson and Roger Ulrich},
year = {2015},
journal = {Cancer Research},
doi = {10.1158/1538-7445.am2015-408},
url = {https://doi.org/10.1158/1538-7445.am2015-408}
}RIS
TY - JOUR TI - Abstract 408: ACP-196, an orally bioavailable covalent selective inhibitor of Btk, modulates the innate tumor microenvironment, exhibits antitumor efficacy and enhances gemcitabine activity in pancreatic cancer AU - Brian J. Lannutti AU - Michael Gulrajani AU - Fanny Krantz AU - Elena Bibikova AU - Todd Covey AU - Katti Jessen AU - Wayne Rothbaum AU - David M. Johnson AU - Roger Ulrich PY - 2015 JO - Cancer Research DO - 10.1158/1538-7445.am2015-408 UR - https://doi.org/10.1158/1538-7445.am2015-408 ER -
APA
Lannutti, B. J., Gulrajani, M., Krantz, F., Bibikova, E., Covey, T., Jessen, K., Rothbaum, W., Johnson, D. M., & Ulrich, R. (2015). Abstract 408: ACP-196, an orally bioavailable covalent selective inhibitor of Btk, modulates the innate tumor microenvironment, exhibits antitumor efficacy and enhances gemcitabine activity in pancreatic cancer. Cancer Research. https://doi.org/10.1158/1538-7445.am2015-408
Source records
- crossref · retrieved 2026-11-06T06:38:37.902Z